Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-26-057263
Filing Date
2026-05-07
Accepted
2026-05-07 17:02:36
Documents
15
Effectiveness Date
2026-05-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2613947d1_s8.htm S-8 54428
2 EXHIBIT 5.1 tm2613947d1_ex5-1.htm EX-5.1 12954
3 EXHIBIT 23.1 tm2613947d1_ex23-1.htm EX-23.1 1910
4 EX-FILING FEES tm2613947d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16379
5 GRAPHIC tm2613947d1_ex5-1img001.jpg GRAPHIC 13079
6 GRAPHIC tm2613947d1_ex5-1img002.jpg GRAPHIC 2593
  Complete submission text file 0001104659-26-057263.txt   228236

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2613947d1_ex-filingfees_htm.xml XML 5088
Mailing Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-295655 | Film No.: 26954713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)